Vivera Pharmaceuticals v. Alternate Health Corp. C
Respondents Alternate Health Corp. and Alternate Health USA, Inc. (collectively, Alternate) held a license for a sublingual (under the tongue) dissolving tablet for delivering marijuana-derived compounds. Appellant Vivera Pharmaceuticals Inc. (Vivera) claimed that the license was restricted to nutraceutical (nonpharmaceutical) products, a claim Alternate disputed. The parties sought relief in the trial court to resolve the dispute. After a bench trial, the trial court agreed with Alternate, that its license gave Alternate the rights to nutraceutical and pharmaceutical applications. Vivera appeals and contends that the trial court erred in interpretating the agreement. We disagree and affirm the judgment.
Comments on Vivera Pharmaceuticals v. Alternate Health Corp. C